Related Experiment Video
Updated: May 28, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Infantile nephropathic cystinosis
Amira Peco-Antić1, Mirjana Kostić, Radovan Bogdanović
1University Children's Hospital, Belgrade, Serbia. amira@udk.bg.ac.rs
Insights
Infantile nephropathic cystinosis (INC) is rare in Serbian children with end-stage renal disease (ESRD). Diagnosis delays were noted, impacting long-term outcomes despite kidney transplants.
Area of Science:
- Pediatric Nephrology
- Metabolic Disorders
- Genetic Diseases
Background:
- Infantile nephropathic cystinosis (INC) is a lysosomal storage disorder.
- It results from impaired cystine transport, leading to cellular accumulation.
- This metabolic defect affects multiple organs, including the kidneys.
Purpose of the Study:
- To determine the prevalence of INC in Serbian pediatric end-stage renal disease (ESRD) patients.
- To describe the clinical features, treatment, and outcomes of INC in this population.
- To provide an updated perspective on INC in Serbia.
Main Methods:
- Retrospective analysis of the Serbian Paediatric Renal Replacement Therapy (RRT) database.
- Inclusion criteria: patients with INC who started RRT before age 19 (1980-2008).
- Evaluation of clinical data, therapies, and patient outcomes.
Main Results:
- INC prevalence was low: 3 out of 298 pediatric ESRD patients (1%).
- Diagnosis of cystinosis was delayed (mean 6 years) despite early infantile symptoms and Fanconi syndrome.
- All patients received kidney transplants; long-term outcomes varied, with one patient on dialysis due to graft failure and two with good graft function but growth retardation.
Conclusions:
- Infantile nephropathic cystinosis is uncommon in Serbian pediatric ESRD patients.
- Delayed diagnosis of cystinosis is a significant issue, even with typical disease presentation.
- Early diagnosis and management are crucial for improving long-term outcomes in INC.
Introduction:
Infantile nephropathic cystinosis (INC) is a metabolic disorder due to impaired carrier-mediated transport of cystine out of cellular lysosomes.
Objective:
To examine the prevalence and clinical characteristics of INC in paediatric patients with endstage renal disease (ESRD) in Serbia and give a recent statement of the disease.
Methods:
ESRD database of the Centre for Paediatric Renal Replacement Therapy (RRT) in Serbia was used to identify all patients with INC who started RRT before age of 19 years during the period January 1980 - December 2008; their records concerning clinical characteristics, therapy and outcome were evaluated.
Results:
Only three of 298 paediatric patients with ESRD had INC. The first signs of the illness were recognised during infancy. Fancony syndrome was diagnosed in the second year, but the diagnosis of cystinosis was delayed at mean 6 years. ESRD occurred in the first decade of life. All patients underwent cadaver kidney transplantation. At the end of the study period all patients were alive. A 31-year-old female patient was on maintenance chemodialysis due to graft failure after functioning for 11 years. She was growth retarded, single, unemployed, with severe signs of renal dystrophy. Two male patients (14.3 and 14.7 years old) had normal graft function, normal education, and good quality of life, although they were also severe growth retarded.
Conclusion:
The prevalence of infantile nephropathic cystinosis is low in Serbia. The diagnosis of cystinosis was delayed in all patients, although they exhibited the typical course of the disease.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Related Concept Videos
Inborn Errors of Metabolism
Nephrotic Syndrome I : Introduction
Nephrons
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Calculi I: Introduction
Lysosomal Hydrolases